The CBOs initial score of the Baucus bill suggests it will reduce the deficit, but there are many caveats, especially on physician payments.
While the United States is often portrayed as having the most troubled health system among developed nations, every country has serious issues, including Canada.
AHIP presents evidence on the value of Medicare Advantage plans in delivering more efficient and effective care.
Researchers associated with the Dartmouth Atlas project reinforce their viewsg on high health costs in a NEJM Perspective.
Everybody says we need cost control and expanded access, but nobody wants to pony up.
Geographic variation in health spending is hot, but the reasons for it are still murky.
While Massachusetts is the state health care reform example most often referred to in the discussion over federal reform efforts, Tennessee’s earlier program to extend coverage may also offer lessons.
An analysis of England’s pay-for-performance system finds improvement but some interesting trends and concerns as well.
Between lobbying and price increases, drug manufacturers are doing a good job of protecting their economic interests.
As health reform heats up, the public needs to be careful about what politicians say; they seldom are completely accurate.
A number of reports and commentaries have recently been issued on comparative effectiveness research.
A new UnitedHealth Group report identifies $332 billion over ten years in administrative cost savings.
Common Cause has issued a report detailing the amounts health groups are spending on campaign contributions and lobbying.